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Infantile myoﬁbromatosis (IM) is a very rare clinical entity consisting of ﬁbrous proliferation occurring in
infants and children. We report the case of a male child with the occurrence of multiple soft tissue
nodules. Myoﬁbromatosis was diagnosed on histopathological examination of the lesions. The charac-
teristic clinical, radiologic and histopathologic features of this process are reviewed along with diagnostic
and therapeutic options.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.IM is a rare tumor of infancy and childhood, typically presenting
as a ﬁrm, nodular mass involving soft tissue, bone or viscera [1,2].
Approximately one-third of cases involve the head and neck. IM
occurs in solitary, multiple, and generalized forms, with similar
histology but different clinicopathologic and prognostic implica-
tions. We describe the case of a boy with myoﬁbromatosis pre-
senting with multiple nodules in the skin, muscle, and
subcutaneous tissues of the trunk.
1. Case report
A three year-old boy presented with a mass on the left side of
neck, which had been expanding over the previous month.
The child was born at full term gestation with a birth weight of
3150 g, and was initially noted to have similar migrating masses on
the forehead and occipital regions in the ﬁrst month of life.
Sometimes thesemasses would disappear spontaneously. The exact
diagnosis eluded several other hospitals.
The family history was unremarkable. He underwent a right
laparoscopic orchidopexy at the age of two and half years, had
never traveled, and was otherwise healthy. He had no history of
injury with good health and normal growth.
The child was found to have a ﬁrm mobile 4 cm mass on the left
side of his neck in other hospital a month ago. There was noBY-NC-ND license (http://
g).
Published by Elsevier Inc. All righterythema nor other skin changes. He remained afebrile. The mass
continued to slowly expand despite applying local physiotherapy
on the local lesion and intravenous antibiotics in another hospital.1.1. Physical examination
Priot to his presentation and through his evaluation he had
normal vital signs. He had a soft tissue nodule extending from the
left shoulder to the occiput about 12  7 cm in size, which was
approximately 2 cm raised above the surface of skin. The quality of
the mass was moderately ﬁrm, without redness, with local swelling
and tenderness. There was no ﬂuctuance nor or pitting with ﬁnger
pressure. The boundaries were indistinct. Blood tests to assess
complete blood count (CBC), lever functions, and renal function
were all normal. Paragonimiasis skin test was negative. Cervical
vertebra and chest x-ray, as well as ultrasound evaluation of
liver, gallbladder, and kidneys were unremarkable. CT scan was
concerning for inﬂammation causing the soft tissue swelling on the
back of his neck.
Because of rapid enlargement of themass, a full thickness biopsy
was performed on the lesion including overlying skin, fascia and
degenerative muscle for pathologic diagnosis. Histological exami-
nation showed that there was proliferation of capillaries, lymphatic
vessels and fat tissue, which suggested inﬂammation and seemed
to exclude the possibility of malignant tumor. He was treated with
anti-inﬂammatories after the biopsy. A new painless mass rapidly
appeared on his back and grew to 20  6.2 cm in 5 days, while the
original neck lesion began to diminish. The patient underwent
partial surgical removal of the newly appeared lesion. Histologicals reserved.
Fig. 2. A boy with multiple nodules in the back was presented.
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tures of IM (Fig. 1). The spindle cells showed a myogenic character
with strongly positive alpha-smooth muscle actin staining.
After the second biopsy, a progressive increase occurred in the
lesions which involved the right neck and the left anterior of chest
wall. Antibiotics, anti-inﬂammatories and traditional Chinese
medicine were not successful in slowing the growth of the lesions.
Seven years in out-patient follow-up revealed that the lesions
continued to grow and new lesions appeared withmultiple nodules
on the back, all lesions were ﬁrm and elevated (Fig. 2). Both sides of
the shoulder joint and neck were involved with limitation of
motion.
2. Discussion
Infantile myoﬁbromatosis was ﬁrst reported by Stout as
congenital generalized ﬁbromatosis in 1954 [3]. Several names
were used for describing IM, including the following: multiple
mesenchymal hamartoma, multiple vascular leiomyoma of the
newborn, diffuse congenital ﬁbromatosis, congenital multiple
ﬁbromatosis, generalized hamartomatosis, and multiple congenital
mesenchymal tumor. The term infantile myoﬁbromatosis was ﬁrst
coined by Chun and Enzinger in 1981 [4].
IM is a descriptive term for a rare benign soft tissue tumor. The
etiology of IM is uncertain. Autosomal dominant, recessive and
polygenic modes of inheritance have been reported [5,6]. Literature
on IM is scant. IM is a mesenchymal disorder presenting multiple
soft tissue nodules on the scalp, trunk and subcutaneous tissue, and
can affect internal organs such as the liver, kidney and boneFig. 1. (A) Proliferation of spindle-shaped or oval ﬁbroblastic cells and ﬁbrous collagen matrix, atrophy of muscle cells (20). (B) In some areas, spindle cells were rich in blood
vessels, which were positive for alpha-smooth muscle actin (20). (CeD) spindle cells among adipose cells (C) or striated muscle cells (D), which were positive for alpha-smooth
muscle actin (C 40, D 20).
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threatening eventually.
Histologically it is characterized by two cell types arranged in a
biphasic pattern [7]; namely centrally positioned small rounded
cells with pale staining nuclei and eosinophilic cytoplasm and
peripherally elongated spindle cells. The lesions show the features
of proliferation of spindle-shaped or oval ﬁbroblastic cells and
ﬁbrous collagen matrix, atrophy of muscle cells with hydropic
changes, and mucoid or degeneration of collagen matrix in soft
tissues. Immunohistochemically the nodules may be found to be
positive for alpha smoothmuscle actin, but negative for S-100 actin.
Prior reports have documented spontaneous regression of IM.
Careful follow-up must be done, as recurrences after regression
may occur [8]. Chung reported a 7% recurrence rate [5]. Recurrences
after 8 and 15 years have been reported.
No effective treatment has been identiﬁed [9]. Antibiotics have
been ineffective. In aggressive cases, limited success has been
achieved by treatment with radiotherapy, steroid injection,
chemotherapy and combined chemo-radiation therapy [10]. Alpha
interferon and the anti-estrogen agent tamoxifen have also been
used in some patients with infantile myoﬁbromatosis [11,12], but no
improvement was seen. There is no consensus between chemo-
therapy, radiotherapy, steroid injection, interferon therapy.
In our patient, the lesions have slowly involved the shoulder
joints and neck of the patient, but is not life threatening at this
point. The prognosis may be worse if involvement occurs of visceral
organs.
3. Conclusion
IM usually develops at birth or during the ﬁrst years of life. The
presence of alpha smooth muscle actin in the spindle cells indicates
the diagnosis of infantile myoﬁbromatosis. The case described hereis multicentric IM with multiple nodules in the skin, muscle, and
subcutaneous tissues of the trunk.
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